文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

审视创伤中潜在可预防死亡:我们能做得更好吗?

Examining potentially preventable mortality in trauma: What can we do better?
PubMed 文献 · J Trauma Acute Care Surg · 2026-10-02
一句话结论在成熟创伤系统中,约四分之一经审查的创伤死亡为潜在可预防死亡,最常见原因为不可控出血,枪伤或其他穿透伤患者风险最高。

本研究基于LiTES网络(超过30个EMS机构、8个一级创伤中心)的前瞻性观察数据,建立潜在可预防死亡(PPM)审查项目,按预设的院前患者/损伤特征和死因选择病例审查。2618例死亡中391例被审查,99例(25.3%)判定为PPM。PPM与非PPM患者就诊时生理状态相似,但PPM中男性、黑人或非裔美国人、枪伤或其他穿透伤比例更高。PPM最常见死因为不可控出血(53%),其次为多器官衰竭(19%)、ARDS/原发性呼吸衰竭(9.1%)和凝血病(6.1%);出血和凝血病所致死亡发生最早。

要点

  • 2618例创伤死亡中391例按预设标准审查,99例(25.3%)判定为潜在可预防死亡。
  • PPM最常见死因为不可控出血(53%),其次多器官衰竭(19%)、ARDS/原发性呼吸衰竭(9.1%)、凝血病(6.1%)。
  • 出血和凝血病所致死亡在救治过程中发生最早,提示需早期强化出血管理。
  • PPM中男性、黑人或非裔美国人、枪伤或其他穿透伤比例高于非PPM,为最高风险人群。
  • PPM与非PPM患者就诊时生理状态相似,提示仅凭生理指标难以识别可预防死亡。

适用人群与场景

  • LiTES网络内超过30个EMS机构转运至美国8个一级创伤中心的严重创伤患者。
  • 审查病例按预设的院前患者/损伤特征和死因清单选择,非全部死亡病例。

诊断标准与关键阈值

  • 潜在可预防死亡(PPM)判定:由研究站点主要研究者报告死因,数据协调中心生成报告,经LiTES执行运营委员会和站点PI审查确定。
  • 原文未提及具体的PPM判定评分界值或启动/停止阈值。

处置流程与药物剂量

  • 结论建议改进出血管理,尤其针对枪伤和其他穿透伤。

红旗征与不能漏的情况

  • 不可控出血为PPM最常见死因(53%),且发生最早。
  • 凝血病为PPM死因之一(6.1%),发生早。
  • 枪伤或其他穿透伤患者PPM风险最高。

研究设计与关键结果

  • 研究类型:前瞻性观察研究的亚组分析(证据等级Level III),数据来自LiTES网络(超过30个EMS机构、8个一级创伤中心)。
  • 2618例死亡中391例按既定标准审查,99例(25.3%)判定为PPM。
  • PPM与非PPM就诊时生理状态相似;PPM中男性、黑人或非裔美国人、枪伤或其他穿透伤比例更高。
  • PPM死因:不可控出血53%、多器官衰竭19%、ARDS/原发性呼吸衰竭9.1%、凝血病6.1%;出血和凝血病所致死亡发生最早。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究的亚组分析,原文标注Level III。
  • 局限:仅审查391/2618例死亡(按预设标准选择),非全部死亡;PPM判定依赖站点PI报告和执行委员会审查,可能存在主观性;原文未提及多中心以外的其他设计局限。

对床旁实践的改变

  • 在成熟创伤系统中仍应开展PPM审查,约四分之一经审查死亡可能可预防。
  • 应优先改进出血管理,尤其针对枪伤和其他穿透伤患者。
  • 对男性、黑人或非裔美国人及穿透伤患者需提高警惕,因其PPM风险最高。
  • 出血和凝血病所致死亡发生最早,提示早期干预窗口的重要性。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Trauma systems have undergone substantial evolution over the past several decades. However, we have yet to achieve the National Academies of Sciences, Engineering, and Medicine goal of zero preventable deaths from injury. In this study, we examined preventable deaths within advanced trauma systems to identify opportunities for further improvement.

METHODS: Task Order One, coordinated within the Linking Investigators in Trauma and Emergency Medical Services Network (LiTES) that included over 30 emergency medical service (EMS) agencies transporting to eight level 1 trauma centers in the United States, created an extensive database of severely injured trauma patients. A potentially preventable mortality (PPM) program was developed. Cause of death was reported by study site primary investigators (PIs), cases were selected for review by a prespecified list of prehospital patient/injury characteristics and cause of death. Reports were generated by the data coordination center and reviewed by the LiTES Executive Operating Committee and the site PI.

RESULTS: Of 2,618 deaths, 391 were reviewed based on established criteria. Of these, 99 (25.3%) were determined to be PPM. For reviewed cases, presenting physiology was similar between PPM and non-PPM patients. Higher proportions of PPM compared with non-PPM were seen in patients who were male, black or African American, with a mechanism of firearm injury or other penetrating injury. The most common cause of PPM was uncontrolled hemorrhage (53%) followed by multiple organ failure (19%), ARDS/primary respiratory failure (9.1%), and coagulopathy (6.1%). Deaths due to uncontrolled hemorrhage and coagulopathy occurred earliest during care.

CONCLUSIONS: In this study, we found that approximately one of four reviewed deaths from injury was potentially preventable. Patients who were male, Black or African American, or sustained firearm or other penetrating injuries were at the highest risk for PPM. On the basis of these data, improvements in hemorrhage management, particularly for firearm and other penetrating injuries, are needed.

LEVEL OF EVIDENCE: Level III, sub-analysis of prospective observational study.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Brito AMP, Wisniewski SR, Jackson A, et al. Examining potentially preventable mortality in trauma: What can we do better? J Trauma Acute Care Surg. 2026. PMID: 42826344. doi:10.1097/TA.0000000000005162

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。